84 related articles for article (PubMed ID: 15209398)
1. Pharmacogenetics to predict drug-related adverse events.
Hosford DA; Lai EH; Riley JH; Xu CF; Danoff TM; Roses AD
Toxicol Pathol; 2004; 32 Suppl 1():9-12. PubMed ID: 15209398
[TBL] [Abstract][Full Text] [Related]
2. Identification of a pharmacogenetic effect by linkage disequilibrium mapping.
Xu CF; Lewis KF; Yeo AJ; McCarthy LC; Maguire MF; Anwar Z; Danoff TM; Roses AD; Purvis IJ
Pharmacogenomics J; 2004; 4(6):374-8. PubMed ID: 15303110
[TBL] [Abstract][Full Text] [Related]
3. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
Roses AD
Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
[TBL] [Abstract][Full Text] [Related]
4. A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.
Danoff TM; Campbell DA; McCarthy LC; Lewis KF; Repasch MH; Saunders AM; Spurr NK; Purvis IJ; Roses AD; Xu CF
Pharmacogenomics J; 2004; 4(1):49-53. PubMed ID: 14647407
[TBL] [Abstract][Full Text] [Related]
5. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of antiretrovirals.
Tozzi V
Antiviral Res; 2010 Jan; 85(1):190-200. PubMed ID: 19744523
[TBL] [Abstract][Full Text] [Related]
7. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity?
Nolan D; Gaudieri S; Mallal S
J HIV Ther; 2003 May; 8(2):36-41. PubMed ID: 12838163
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacogenetics. Tailored therapy in medicine -- opportunities and challenges].
Scharplatz M; Puhan M; Steurer J; Bachmann LM
Praxis (Bern 1994); 2004 Mar; 93(10):359-65. PubMed ID: 15052854
[TBL] [Abstract][Full Text] [Related]
10. Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.
Guo Y; Shi L; Hong H; Su Z; Fuscoe J; Ning B
Sci China Life Sci; 2013 Feb; 56(2):119-24. PubMed ID: 23393027
[TBL] [Abstract][Full Text] [Related]
11. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
[TBL] [Abstract][Full Text] [Related]
12. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.
Nelson MR; Bacanu SA; Mosteller M; Li L; Bowman CE; Roses AD; Lai EH; Ehm MG
Pharmacogenomics J; 2009 Feb; 9(1):23-33. PubMed ID: 18301416
[TBL] [Abstract][Full Text] [Related]
14. Analysis of association at single nucleotide polymorphisms in the APOE region.
Martin ER; Gilbert JR; Lai EH; Riley J; Rogala AR; Slotterbeck BD; Sipe CA; Grubber JM; Warren LL; Conneally PM; Saunders AM; Schmechel DE; Purvis I; Pericak-Vance MA; Roses AD; Vance JM
Genomics; 2000 Jan; 63(1):7-12. PubMed ID: 10662539
[TBL] [Abstract][Full Text] [Related]
15. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.
Lucas A; Nolan D; Mallal S
J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695
[TBL] [Abstract][Full Text] [Related]
16. Will pharmacogenomic discoveries improve HIV therapeutics?
Haas DW
Top HIV Med; 2005; 13(3):90-5. PubMed ID: 16170225
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.
Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R
Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular pharmacogenetics in the SNP era.
Mooser V; Waterworth DM; Isenhour T; Middleton L
J Thromb Haemost; 2003 Jul; 1(7):1398-402. PubMed ID: 12871273
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.
Berka N; Gill JM; Liacini A; O'Bryan T; Khan FM
Hum Immunol; 2012 Feb; 73(2):164-7. PubMed ID: 22197535
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
Hetherington S; Hughes AR; Mosteller M; Shortino D; Baker KL; Spreen W; Lai E; Davies K; Handley A; Dow DJ; Fling ME; Stocum M; Bowman C; Thurmond LM; Roses AD
Lancet; 2002 Mar; 359(9312):1121-2. PubMed ID: 11943262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
